FULLY HUMAN MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AGAINST CD276 FOR THE TREATMENT OF SOLID TUMORS
US Application 19/503,627
Filed on 2026-01-20
Filed on 2026-01-20
FULLY HUMAN MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AGAINST CD276 FOR THE TREATMENT OF SOLID TUMORS
Australia
2024295016
Filed on 2026-01-15
2024295016
Filed on 2026-01-15
FULLY HUMAN MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AGAINST CD276 FOR THE TREATMENT OF SOLID TUMORS
Canada
3299104
Filed on 2026-01-19
3299104
Filed on 2026-01-19
T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY
Germany
21787116.9
Filed on 2023-03-28
21787116.9
Filed on 2023-03-28
T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY
Italy
21787116.9
Filed on 2023-03-28
21787116.9
Filed on 2023-03-28
T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY
France
21787116.9
Filed on 2023-03-28
21787116.9
Filed on 2023-03-28
T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY
Spain
21787116.9
Filed on 2023-03-28
21787116.9
Filed on 2023-03-28
TEM8 MONOCLONAL ANTIBODIES AND THEIR USE
Patent Cooperation Treaty
PCT/US2026/012882
Filed on 2026-01-28
PCT/US2026/012882
Filed on 2026-01-28
Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation
China
202610034476.X
Filed on 2026-01-12
202610034476.X
Filed on 2026-01-12
Chimeric Antigen Receptors Targeting CD-19
Japan
2025-283967
Filed on 2025-12-26
2025-283967
Filed on 2025-12-26